Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Dexketoprofen trometamol approved in E.U. countries

Jan. 22, 1998

New 5-HT1B antagonists developed at SmithKline Beecham

Jan. 22, 1998

Pfizer presents new serotonergic agents

Jan. 22, 1998

Connetics completes phase I/II MS trial; European patent granted

Jan. 22, 1998

Pfizer to develop Nastech formulation of sleep aid

Jan. 21, 1998

Pharmacological profile of broad-spectrum, nonopioid analgesic described by Abbott

Jan. 21, 1998

Controlled-release tramadol under development

Jan. 20, 1998

Zeneca commits to development of Zomig line extensions

Jan. 20, 1998

Novel atypical antipsychotic agent presented by Lundbeck

Jan. 20, 1998

MS&D reveals new class of antimigraine agents

Jan. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...